Compare Stocks

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMT American Tower	$172.96 -0.2%	$190.60	$154.58 ▼ $219.10	$80.84B	0.67	2.61 million shs	1.86 million shs
CHEOF Cochlear	$204.04	$219.28	$145.73 ▼ $230.46	N/A	N/A	164 shs	N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMT American Tower	-0.22%	+1.15%	-10.89%	-12.33%	-13.67%
CHEOF Cochlear	0.00%	-2.37%	-8.07%	+0.04%	+25.02%

The World's First "$20 Trillion Drug?" (Ad)

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMT American Tower	4.9838 of 5 stars	4.4	5.0	2.5	3.1	2.7	2.5	1.9
CHEOF Cochlear	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMT American Tower	2.82	Moderate Buy	$217.36	25.67% Upside
CHEOF Cochlear	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest CHEOF, 4DX, ADR, and AMT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/15/2024	AMT American Tower	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$183.00 ➝ $196.00
4/8/2024	AMT American Tower	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$205.00
3/5/2024	AMT American Tower	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$224.00 ➝ $234.00
2/28/2024	AMT American Tower	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$235.00 ➝ $228.00
2/28/2024	AMT American Tower	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$236.00 ➝ $230.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMT American Tower	$11.14B	7.24	$9.88 per share	17.50	$23.30 per share	7.42
CHEOF Cochlear	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMT American Tower	$1.48B	$3.18	54.39	16.76	1.37	13.31%	12.80%	2.24%	4/30/2024 (Confirmed)
CHEOF Cochlear	N/A	$1.64	124.26	∞	N/A	N/A	N/A	N/A	N/A

Latest CHEOF, 4DX, ADR, and AMT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/30/2024	N/A	AMT American Tower	$2.45	N/A	-$2.45	N/A	N/A	N/A
2/27/2024	12/31/2023	AMT American Tower	$2.10	$0.94	-$1.16	$0.18	$2.74 billion	$2.79 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMT American Tower	$6.48	3.75%	+12.50%	203.77%	N/A
CHEOF Cochlear	$1.27	0.62%	N/A	77.34%	N/A

Latest CHEOF, 4DX, ADR, and AMT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/14/2024	AMT American Tower	quarterly	$1.62	3.3%	4/11/2024	4/12/2024	4/26/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMT American Tower	3.29	0.69	0.69
CHEOF Cochlear	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
AMT American Tower	92.69%
CHEOF Cochlear	22.47%

Insider Ownership

Company	Insider Ownership
AMT American Tower	0.24%
CHEOF Cochlear	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AMT American Tower	5,643	466.35 million	465.23 million	Optionable
CHEOF Cochlear	4,800	N/A	N/A	Not Optionable

CHEOF, 4DX, ADR, and AMT Headlines

Source	Headline
	Cochlear (OTCMKTS:CHEOF) Stock Price Down 0.5% americanbankingnews.com - April 19 at 2:22 AM
	Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF) markets.businessinsider.com - July 26 at 8:16 AM
	After long gap, Kerala govt approves funds to upgrade cochlear implant devices newindianexpress.com - July 24 at 7:57 AM
	Cochlear implant for children: Kerala government sanctions Rs 59.47 lakhs english.mathrubhumi.com - July 24 at 7:57 AM
	A tribute to Oommen Chandy: Congress to help 50 hearing-impaired children onmanorama.com - July 23 at 3:32 PM
	Funds allocated for upgrade of cochlear implants of 25 children thehindu.com - July 23 at 10:32 AM
	How Oommen Chandy heard a widow out and launched cochlear implant scheme when he became CM onmanorama.com - July 20 at 12:37 AM
	Chandy’s Cochlear Implant Scheme hits hurdles, parents seek government help msn.com - July 20 at 12:37 AM
	Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe benzinga.com - July 19 at 9:36 AM
	7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctor msn.com - July 18 at 1:15 PM
	Oommen Chandy: Humane leader who put patients first, say health experts msn.com - July 18 at 8:15 AM
	Minerva mentors giving stars a sporting chance theaustralian.com.au - July 17 at 10:18 AM
	Over Rs 86 crore spent from Maharashtra CM medical relief fund uniindia.com - July 14 at 12:50 PM
	Townsville University Hospital audiology review finds failures with testing, cochlear implants abc.net.au - July 13 at 10:40 AM
	‘Urgent’ treatment needed for children after Townsville University Hospital audiology failures townsvillebulletin.com.au - July 12 at 11:21 PM
	Maureen able to listen to Slim Dusty thanks to life changing cochlear implant sheppnews.com.au - July 11 at 8:01 PM
	Sensorion submits clinical trial application with UK MHRA for lead gene therapy candidate OTOF-GT pharmabiz.com - July 11 at 10:00 AM
	Morgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF) markets.businessinsider.com - July 10 at 11:30 PM
	Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK benzinga.com - July 10 at 8:29 AM
	BIRRD to conduct 25 cochlear implant surgeries a month thehansindia.com - July 8 at 12:25 AM
	Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study benzinga.com - July 5 at 5:49 AM
	BPCL Supports Cochlear Implantation for 30 Underprivileged Children in Maharashtra devdiscourse.com - July 4 at 9:36 AM
	First cochlear implant surgery performed in Latur uniindia.com - June 27 at 6:22 PM
	Vanderbilt University Medical Center names CXO beckershospitalreview.com - June 27 at 1:22 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

American Tower

NYSE:AMT

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.

Cochlear

OTCMKTS:CHEOF

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial